clinical trial

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial

• Moreno R,
• Garcia E,
• Teles R,
• Almeida M,
• Carvalho H,
• Sabate M,
• Martin-Reyes R,
• Rumoroso J,
• Galeote G,
• Goicolea F,
• Moreu J,
• Mainar V,
• Mauri J,
• Ferreira R,
• Valdes M,
• de Prado A,
• Martin-Yuste V,
• Jimenez-Valero S,
• Sánchez-Recalde A,
• Calvo L,
• de Sa E,
• Macaya C,
• López-Sendón J-L

EuroIntervention 2010;6:112-116

Published in Volume 6 Number 1, May 2010

Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™

• Duckers H,
• Soullié T,
• den Heijer P,
• Rensing B,
• de Winter R,
• Rau M,
• Mudra H,
• Silber S,
• Benit E,
• Verheye S,
• Wijns W,
• Serruys PW

EuroInterv.2007;3:350-358

Published in Volume 3 Number 3, November 2007

Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial

• Morice M-C,
• Bestehorn H-P,
• Carrié D,
• Macaya C,
• Aengevaeren W,
• Wijns W,
• Dubois C,
• de Winter R,
• Verheye S,
• Hoffmann S,
• Pachinger O,
• Di Mario C

EuroInterv.2006;2:45-52

Published in Volume 2 Number 1, May 2006